Kopin Corp.
KOPN is executing better operationally, but at $5.08 the stock already discounts a large part of the 2027 defense and microdisplay upside while profitability is still only promised for Q4 2026 and several growth programs remain pre-production.
KOPN is no longer the same operating story it was a year ago. Revenue is moving, losses are narrowing, and there is finally a visible path to breakeven. Q2 2026 revenue of $12.7M, up 51% y/y, plus EBITDA margin improving to -8.4%, shows the model has operating leverage when programs ship. Management also has real order evidence behind the optimism, with over $45M of orders received in 2026 and explicit guidance that the second half should exceed the prior $52M-$60M revenue outlook. If this were a question of whether the company is improving, the answer would be yes.
The problem is the stock. At $5.08, KOPN is trading 53.5% above its 200-day average, only 23.1% below the 52-week high, after a 39.94% one-month rally. That setup matters because the core upside drivers are still mostly future-tense. Management says, "Importantly, we expect to begin generating GAAP profitability and positive free cash flow in our fourth quarter of this year." Expected is not achieved. Sentinel FPV volume orders are expected only in late Q4, microLED manufacturing is targeted for mid-2027, and Neural I/o production revenue has already been pushed to 2028. The market is capitalizing milestones before they are de-risked.
The case depends on three things. First, Q4 2026 must actually turn profitable and cash generative, because without that, the current run becomes hard to defend on any earnings basis. Second, Sentinel FPV must convert prototype demand into volume orders. Management framed 2027 as tens of millions of dollars, potentially more, but that remains tied to Drone Dominance program outcomes rather than contracted production today. Third, manufacturing upgrades must convert from engineering promise into economics, specifically the 15-point gross margin lift from in-house OLED deposition and the ~$1M opex savings from automation.
What keeps conviction low rather than high is that the company is not fundamentally broken. Balance-sheet risk looks manageable, with debt/equity of 0.02 and a 2.61 current ratio, and the niche technology stack has legitimate strategic value. But the earnings track record remains noisy, with 5 misses in the last 8 reports, and $26.0M restricted cash tied up in litigation still limits flexibility. Good business trajectory, poor entry price. That is a SELL, not because the story is false, but because the stock is already pricing too much of it.
Late-Q4 FPV volume orders hit, Q4 turns sustainably profitable, and 2027 bookings support management's tens of millions defense growth narrative.
Operations improve as guided, but investors reset the multiple once they separate real 2026 revenue from still-uncertain 2027 program upside.
Q4 profitability slips, FY26 revenue lands only modestly above $52M-$60M, and 2027 Sentinel or Neural I/o timing pushes out again.
Quant call (SELL) diverges from analyst consensus (Strong Buy: 3 buy / 0 hold / 0 sell) — resolve explicitly.
We don't buy stocks where they are, we buy them where they're going.
Forward earnings power is improving from near-zero, but it is still mostly a 2027 story, not a 2026 fact. The trailing P/E is N/A and even forward valuation is hard to defend cleanly because profitability depends on a Q4 2026 step-change plus 2027 defense ramps, while Neural I/o production revenue now likely slips to 2028. The moat looks better than it did three years ago because defense-qualified microdisplays, bright color microLED capability at 150,000+ nits, and optical interconnect partnerships create real niche value, but over the next 3-5 years that moat still has to survive larger display, photonics, and defense suppliers. AI is a potential tailwind through Neural I/o optical interconnects, yet today it is mostly development revenue and ecosystem NDAs, not scaled product revenue, so the stock is ahead of the proof.
- Shares trade at $5.08, versus a quant price target of $3.32, implying -34.6% downside.
- Management only says FY26 revenue should exceed the prior $52M-$60M outlook, with GAAP profitability and positive free cash flow expected in Q4 2026, not yet delivered.
- Price action is stretched, +39.94% in 1 month, +28.61% in 1 week, and 53.5% above the 200-day average, while short interest remains high at 17.45%.
- Q2 2026 revenue grew 51% y/y to $12.7M, and EBITDA margin improved to -8.4%, up 24.3 points vs Q1 and 49.4 points vs prior-year Q2.
- Order intake is real, not theoretical: management said, "To date, we have received over $45 million of orders in 2026."
- Gross profit structure can improve materially if execution lands, with in-house OLED deposition expected to add at least 15 points of gross margin next year and an optical automation program targeting ~$1M annual opex savings.
- 2027 optionality is meaningful, with Sentinel FPV described as tens of millions of revenue potential and Neural I/o development revenue/orders targeted at $20M-$30M in 2027.
- Valuation is being carried by future hopes rather than current earnings power: FY2025 operating margin was -37.0%, net margin -29.5%, and P/E remains N/A.
- Management did not provide a formal updated FY26 range, only that revenue should exceed the prior $52M-$60M outlook, which leaves little hard basis for a stock trading near the top quartile of its $1.75-$6.61 52-week range.
- A meaningful balance-sheet constraint remains, with $26.0M restricted cash tied largely to the BlueRadios litigation appeal bond.
- Execution history is uneven: over the last eight reported quarters/trading updates in the dataset, KOPN posted 5 misses and 3 beats, including a 2026-05-12 EPS miss of -100.0% and a 2025-08-12 miss of -125.1%.
| Metric | Value | Context |
|---|---|---|
| Price target | $3.32 | Ground-truth target, -34.6% vs current $5.08, low confidence |
| Current price / 52-week position | $5.08 | -23.1% vs $6.61 high, +53.5% vs $3.31 200-day average |
| FY2025 revenue | $0.0B | Reported as 23798.1% YoY, data scale likely rounded, use caution |
| FY2025 EPS | $0.01 | -80.5% YoY, profitability still minimal |
| FY2025 operating margin | -37.0% | Improved from -85.6% in prior FY |
| FY2025 net margin | -29.5% | Still loss-making on a full-year basis |
| Q2 2026 revenue | $12.7M | +51% y/y, driven by IBAS, Fabric.AI, and Army/AR development programs |
| Q2 2026 EBITDA margin | -8.4% | Up 24.3 pts vs Q1 and 49.4 pts vs prior-year Q2 |
| FY2026 outlook | Above $52M-$60M revenue | No formal updated range, Q4 GAAP profitability and positive FCF expected |
| Valuation | P/S 0.06 | P/B 0.01 | P/E N/A | Peer avg P/E 24.0, but earnings base is too weak for clean P/E comparison |
| Balance sheet | Debt/Equity 0.02 | Debt/EBITDA 0.36 | Current ratio 2.61 | Leverage is low, liquidity adequate, but $26.0M restricted cash limits flexibility |
| Short interest | 17.45% | 27.1M shares, 3.1 days-to-cover, squeeze dynamics can distort near-term price |
The biggest risk to the SELL call is that Q4 2026 profitability arrives on schedule and Sentinel FPV converts late-Q4 prototypes into tens of millions of 2027 revenue, forcing the market to keep capitalizing KOPN on 2027 instead of current losses.
The next key catalyst is the November 11, 2026 earnings report, which must show 2H acceleration toward management's promised Q4 GAAP profitability and positive free cash flow.
Ownership is fairly concentrated for a micro-cap, with the top three institutions holding 48.2%, while insiders own only 2.6%. Short interest is elevated at 17.45%, or 27.1M shares, with 3.1 days-to-cover, which helps explain the violent 1-week 28.61% move and leaves room for squeezes that are technical rather than fundamental. Options positioning is flagged as a positive GEX regime, which can support momentum in the near term, but that is a setup signal, not a valuation support pillar.
Defense was the dominant disclosed contributor on the historical call, up 109% y/y then, and remains central through Army/AR programs and Sentinel FPV.
Q2 2026 growth was driven by IBAS grant revenue, Fabric.AI collaboration revenue, and Army/AR development programs, showing current growth is still partly R&D-led.
Management targets $20M-$30M of development revenue/orders in 2027, while production revenue likely shifts to 2028.
Historical commentary pointed to international defense revenue growing from less than 5% of sales, but current geographic revenue breakout is not provided.
Kopin pointed to a stronger 2H26 and expects Q4 GAAP profitability and free cash flow.
Execution has improved, but credibility is still mixed. On the positive side, management said in the 2024 Q3 call, "We now project over 75 million in orders for 2024 and beyond, potentially the highest annual order total in our company's 40-year history." By 2026, they reported over $45M of orders received year-to-date, which supports that demand did materialize across programs, and they did keep pushing manufacturing upgrades that now point to at least 15 points of gross margin help next year and ~$1M annual opex savings. They also said on the 2024 call that Q4 gross margin would be sequentially higher, "That's the plan." FY2025 operating margin did improve sharply to -37.0% from -85.6%, which supports a real cost and mix improvement versus that period. But the company has not earned full trust: the earnings record since that call is uneven, with 5 misses and 3 beats, and current guidance again stops short of a formal raised FY26 range. The strategic direction has not changed materially, defense displays plus adjacent photonics and manufacturing automation remain the playbook, but timelines have slipped on Neural I/o, where production revenue is now likely 2028 rather than 2027.
reflecting the order momentum across the business for 2026, we continue to expect a solid second half exceeding our prior guidance.
Importantly, we expect to begin generating GAAP profitability and positive free cash flow in our fourth quarter of this year.
To date, we have received over $45 million of orders in 2026.
The scale of this opportunity is quite significant. DDP winners have the potential to require tens of thousands of FPV goggles, and volume orders are expected to begin in late Q4, immediately following the DDP Phase 2 evaluations and awards, with requirements for immediate delivery as awards are issued.
it's definitely tens of millions of dollars in new customer orders and deliveries that we would expect in 2027. The scale could double that, quite frankly, depending on who wins the most in the Drone Dominance Gauntlet
Kopin's edge is niche, not broad. It sits in defense-qualified microdisplays, soldier-system optics, and emerging microLED and optical interconnect applications where qualification cycles, low weight, high brightness, and integration know-how matter more than scale alone. That advantage is durable if programs convert to production, but it is not impregnable because larger display, optics, and defense suppliers can attack attractive niches once volumes become meaningful.
Capital allocation is conservative because it has to be. There are no buybacks, no dividends, and no meaningful capex or M&A disclosed in the deep-dive data, while free cash flow is still around break-even and management is focused on reaching positive FCF in Q4 2026. The best capital allocation move from here is operational, converting the OLED deposition line and automation investments into the promised 15-point gross margin lift and ~$1M opex savings.
Rated SELL, Low conviction. KOPN has a better business than it did a year ago, but the stock has moved faster than the fundamentals, and too much of the case rests on milestones that are still ahead, not delivered. The market is paying for Q4 2026 profitability, 2027 FPV volume, and microLED and Neural I/o scale-up before those revenues are locked in. A move back toward the quant engine's $3.32 base value, or hard evidence that Q4 profitability and 2027 production ramps are arriving on time, would change the risk-reward. Until then, this is a stock to avoid chasing.
≣ Full research note tap to expand
Executive Summary
SELL, Low conviction. KOPN rates a SELL at Low conviction. The business is improving, with Q2 2026 revenue up 51% y/y to $12.7M, operating loss narrowing to $3.5M, and management guiding to Q4 GAAP profitability and positive free cash flow, but the stock has run 53.5% above its 200-day average and sits far above the quant engine's $3.32 target. This is not a broken company call, it is a price-versus-proof call: too much of the 2027 story is being paid for before production revenue is in hand.
Investment Thesis
KOPN is no longer the same operating story it was a year ago. Revenue is moving, losses are narrowing, and there is finally a visible path to breakeven. Q2 2026 revenue of $12.7M, up 51% y/y, plus EBITDA margin improving to -8.4%, shows the model has operating leverage when programs ship. Management also has real order evidence behind the optimism, with over $45M of orders received in 2026 and explicit guidance that the second half should exceed the prior $52M-$60M revenue outlook. If this were a question of whether the company is improving, the answer would be yes.
The problem is the stock. At $5.08, KOPN is trading 53.5% above its 200-day average, only 23.1% below the 52-week high, after a 39.94% one-month rally. That setup matters because the core upside drivers are still mostly future-tense. Management says, "Importantly, we expect to begin generating GAAP profitability and positive free cash flow in our fourth quarter of this year." Expected is not achieved. Sentinel FPV volume orders are expected only in late Q4, microLED manufacturing is targeted for mid-2027, and Neural I/o production revenue has already been pushed to 2028. The market is capitalizing milestones before they are de-risked.
The case depends on three things. First, Q4 2026 must actually turn profitable and cash generative, because without that, the current run becomes hard to defend on any earnings basis. Second, Sentinel FPV must convert prototype demand into volume orders. Management framed 2027 as tens of millions of dollars, potentially more, but that remains tied to Drone Dominance program outcomes rather than contracted production today. Third, manufacturing upgrades must convert from engineering promise into economics, specifically the 15-point gross margin lift from in-house OLED deposition and the ~$1M opex savings from automation.
What keeps conviction low rather than high is that the company is not fundamentally broken. Balance-sheet risk looks manageable, with debt/equity of 0.02 and a 2.61 current ratio, and the niche technology stack has legitimate strategic value. But the earnings track record remains noisy, with 5 misses in the last 8 reports, and $26.0M restricted cash tied up in litigation still limits flexibility. Good business trajectory, poor entry price. That is a SELL, not because the story is false, but because the stock is already pricing too much of it.
Key Metrics
| Metric | Value | Context | ||
|---|---|---|---|---|
| Price target | $3.32 | Ground-truth target, -34.6% vs current $5.08, low confidence | ||
| Current price / 52-week position | $5.08 | -23.1% vs $6.61 high, +53.5% vs $3.31 200-day average | ||
| FY2025 revenue | $0.0B | Reported as 23798.1% YoY, data scale likely rounded, use caution | ||
| FY2025 EPS | $0.01 | -80.5% YoY, profitability still minimal | ||
| FY2025 operating margin | -37.0% | Improved from -85.6% in prior FY | ||
| FY2025 net margin | -29.5% | Still loss-making on a full-year basis | ||
| Q2 2026 revenue | $12.7M | +51% y/y, driven by IBAS, Fabric.AI, and Army/AR development programs | ||
| Q2 2026 EBITDA margin | -8.4% | Up 24.3 pts vs Q1 and 49.4 pts vs prior-year Q2 | ||
| FY2026 outlook | Above $52M-$60M revenue | No formal updated range, Q4 GAAP profitability and positive FCF expected | ||
| Valuation | P/S 0.06 | P/B 0.01 | P/E N/A | Peer avg P/E 24.0, but earnings base is too weak for clean P/E comparison |
| Balance sheet | Debt/Equity 0.02 | Debt/EBITDA 0.36 | Current ratio 2.61 | Leverage is low, liquidity adequate, but $26.0M restricted cash limits flexibility |
| Short interest | 17.45% | 27.1M shares, 3.1 days-to-cover, squeeze dynamics can distort near-term price |
Financial Strength
Kopin's balance sheet is not the problem. Leverage is light, with debt/equity of 0.02 and debt/EBITDA of 0.36, and liquidity is acceptable with a 2.61 current ratio. The business is also showing genuine margin repair, with FY2025 operating margin improving to -37.0% from -85.6%, then Q2 2026 EBITDA margin tightening to -8.4%. The caution is cash quality, not solvency: free cash flow is not yet sustainably positive, and $26.0M of restricted cash tied to the BlueRadios appeal bond reduces practical balance-sheet flexibility just as the company tries to scale production.
Competitive Position
Kopin's edge is niche, not broad. It sits in defense-qualified microdisplays, soldier-system optics, and emerging microLED and optical interconnect applications where qualification cycles, low weight, high brightness, and integration know-how matter more than scale alone. That advantage is durable if programs convert to production, but it is not impregnable because larger display, optics, and defense suppliers can attack attractive niches once volumes become meaningful.
Management & Guidance
Current guidance is directionally encouraging but still softer than ideal. Management said 2H26 should exceed the prior $52M-$60M revenue outlook and explicitly stated, "Importantly, we expect to begin generating GAAP profitability and positive free cash flow in our fourth quarter of this year." That is supported by $45M+ of 2026 orders, improving quarterly margins, and visible manufacturing initiatives, but credibility is only moderate because the company did not provide a formal updated full-year range and the recent earnings record includes several large misses. The guidance is plausible, not yet proven.
Segment Analysis
- Defense products and programs (At least $10.4M in 2024 Q3 revenue): Defense was the dominant disclosed contributor on the historical call, up 109% y/y then, and remains central through Army/AR programs and Sentinel FPV.
- Funded development and collaboration revenue (Meaningful but undisclosed in FY2026 mix): Q2 2026 growth was driven by IBAS grant revenue, Fabric.AI collaboration revenue, and Army/AR development programs, showing current growth is still partly R&D-led.
- Neural I/o and microLED pipeline (Pre-production): Management targets $20M-$30M of development revenue/orders in 2027, while production revenue likely shifts to 2028.
- Geography (Not disclosed): Historical commentary pointed to international defense revenue growing from less than 5% of sales, but current geographic revenue breakout is not provided.
Capital Allocation
Capital allocation is conservative because it has to be. There are no buybacks, no dividends, and no meaningful capex or M&A disclosed in the deep-dive data, while free cash flow is still around break-even and management is focused on reaching positive FCF in Q4 2026. The best capital allocation move from here is operational, converting the OLED deposition line and automation investments into the promised 15-point gross margin lift and ~$1M opex savings.
Management Execution & Track Record
Execution has improved, but credibility is still mixed. On the positive side, management said in the 2024 Q3 call, "We now project over 75 million in orders for 2024 and beyond, potentially the highest annual order total in our company's 40-year history." By 2026, they reported over $45M of orders received year-to-date, which supports that demand did materialize across programs, and they did keep pushing manufacturing upgrades that now point to at least 15 points of gross margin help next year and ~$1M annual opex savings. They also said on the 2024 call that Q4 gross margin would be sequentially higher, "That's the plan." FY2025 operating margin did improve sharply to -37.0% from -85.6%, which supports a real cost and mix improvement versus that period. But the company has not earned full trust: the earnings record since that call is uneven, with 5 misses and 3 beats, and current guidance again stops short of a formal raised FY26 range. The strategic direction has not changed materially, defense displays plus adjacent photonics and manufacturing automation remain the playbook, but timelines have slipped on Neural I/o, where production revenue is now likely 2028 rather than 2027.
Positioning & Flows
Ownership is fairly concentrated for a micro-cap, with the top three institutions holding 48.2%, while insiders own only 2.6%. Short interest is elevated at 17.45%, or 27.1M shares, with 3.1 days-to-cover, which helps explain the violent 1-week 28.61% move and leaves room for squeezes that are technical rather than fundamental. Options positioning is flagged as a positive GEX regime, which can support momentum in the near term, but that is a setup signal, not a valuation support pillar.
Bull Case
- Q2 2026 revenue grew 51% y/y to $12.7M, and EBITDA margin improved to -8.4%, up 24.3 points vs Q1 and 49.4 points vs prior-year Q2.
- Order intake is real, not theoretical: management said, "To date, we have received over $45 million of orders in 2026."
- Gross profit structure can improve materially if execution lands, with in-house OLED deposition expected to add at least 15 points of gross margin next year and an optical automation program targeting ~$1M annual opex savings.
- 2027 optionality is meaningful, with Sentinel FPV described as tens of millions of revenue potential and Neural I/o development revenue/orders targeted at $20M-$30M in 2027.
Bear Case
- Valuation is being carried by future hopes rather than current earnings power: FY2025 operating margin was -37.0%, net margin -29.5%, and P/E remains N/A.
- Management did not provide a formal updated FY26 range, only that revenue should exceed the prior $52M-$60M outlook, which leaves little hard basis for a stock trading near the top quartile of its $1.75-$6.61 52-week range.
- A meaningful balance-sheet constraint remains, with $26.0M restricted cash tied largely to the BlueRadios litigation appeal bond.
- Execution history is uneven: over the last eight reported quarters/trading updates in the dataset, KOPN posted 5 misses and 3 beats, including a 2026-05-12 EPS miss of -100.0% and a 2025-08-12 miss of -125.1%.
Valuation & Price Target
Engine price target $3.32 (-34.6% vs current), Low confidence.
- P/S Multiple: $1.52 (45% weight)
- Quality-adjusted: $5.85 (20% weight)
- DCF: $375.25 (0% weight)
The rating aligns with the quant baseline of SELL, though for a more qualitative reason than the engine's low-confidence blend alone. The engine target is $3.32, with a wide method spread from P/S $1.52 to Quality-adjusted $5.85 and an unusable DCF $375.25, which itself says the valuation picture is unstable and highly assumption-sensitive. The business quality is decent at 69/100 and risk is low at 34/100, so this is not a balance-sheet distress short. The issue is that at $5.08, investors are paying for successful delivery of Q4 profitability, 2027 FPV volume, microLED manufacturing in mid-2027, and Neural I/o traction even after production timing slipped toward 2028. Sell-side consensus is Strong Buy from only 3 firms, which is low-signal context and not enough to offset the gap between today's price and the still-limited amount of hard delivered earnings power.
Risk Assessment
Risk score 34/100 (Low). The biggest risk to the SELL call is that Q4 2026 profitability arrives on schedule and Sentinel FPV converts late-Q4 prototypes into tens of millions of 2027 revenue, forcing the market to keep capitalizing KOPN on 2027 instead of current losses.
The Bottom Line
Rated SELL, Low conviction. KOPN has a better business than it did a year ago, but the stock has moved faster than the fundamentals, and too much of the case rests on milestones that are still ahead, not delivered. The market is paying for Q4 2026 profitability, 2027 FPV volume, and microLED and Neural I/o scale-up before those revenues are locked in. A move back toward the quant engine's $3.32 base value, or hard evidence that Q4 profitability and 2027 production ramps are arriving on time, would change the risk-reward. Until then, this is a stock to avoid chasing.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr